Literature DB >> 10780501

Baseline-dependency of nicotine effects: a review.

K A Perkins1.   

Abstract

'Rate-dependency', a founding observation of behavioral pharmacology, generally indicates that effects of drugs will be inversely related to the rate of operant responding under control conditions (i.e. decrease in high-rate behaviors and increase in low-rate behaviors). 'Baseline-dependency' encompasses rate-dependency and extends this notion to other drug effects, including those assessed by means other than 'rate' (such as subjective mood self-reports). Although little human research has specifically investigated the effects of nicotine as a function of baseline level of responding, a number of studies suggest baseline-dependent differences in the influence of nicotine on behavioral and cognitive task performance and on subjective mood responses. Results of many animal studies also are very consistent with these observations. Baseline-dependency, perhaps, is most clearly demonstrated in comparisons between groups selected on the basis of specific characteristics (e.g. high vs low 'trait hostility'), or within subjects as a result of acute environmental manipulations (e.g. high vs low 'stress' task). Moreover, baseline-dependency of the effects of nicotine may have broader applicability in explaining individual differences in vulnerability to nicotine dependence, particularly among those with psychiatric disorders (e.g. depression). While individual differences in responses to nicotine may be due to differences in pharmacological sensitivity to nicotine, as commonly assumed, they also may be due partly to individual and situationally determined differences in baseline level of responding on the measure of interest. Consideration of the conditions under which baseline-dependent effects of nicotine are observed may clarify both individual difference and situational influences on responses to nicotine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780501     DOI: 10.1097/00008877-199911000-00006

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  26 in total

1.  Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.

Authors:  Alexandra S Potter; David J Bucci; Paul A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  2011-10-04       Impact factor: 4.530

2.  The Return of Rate Dependence.

Authors:  Amanda J Quisenberry; Sarah E Snider; Warren K Bickel
Journal:  Behav Anal (Wash D C)       Date:  2016-11

Review 3.  Functional brain imaging of nicotinic effects on higher cognitive processes.

Authors:  Paul A Newhouse; Alexandra S Potter; Julie A Dumas; Christiane M Thiel
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

4.  Subjective effects of transdermal nicotine among nonsmokers.

Authors:  Rebecca L Ashare; Joseph S Baschnagel; Larry W Hawk
Journal:  Exp Clin Psychopharmacol       Date:  2010-04       Impact factor: 3.157

Review 5.  Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date.

Authors:  Alexandra S Potter; Geoffrey Schaubhut; Megan Shipman
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

6.  Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.

Authors:  Megan M Kangiser; Linda P Dwoskin; Guangrong Zheng; Peter A Crooks; Dustin J Stairs
Journal:  Behav Pharmacol       Date:  2018-02       Impact factor: 2.293

7.  Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors.

Authors:  S de la Salle; D Smith; J Choueiry; D Impey; T Philippe; H Dort; A Millar; P Albert; V Knott
Journal:  Neuroscience       Date:  2013-03-25       Impact factor: 3.590

8.  Moderation of nicotine effects on covert orienting of attention tasks by poor placebo performance and cue validity.

Authors:  Jonathan J Hammersley; David G Gilbert; Adam Rzetelny; Norka E Rabinovich
Journal:  Pharmacol Biochem Behav       Date:  2016-07-25       Impact factor: 3.533

9.  Rate dependent effects of acute nicotine on risk taking in young adults are not related to ADHD diagnosis.

Authors:  Katherine K Ryan; Sarahjane L Dube; Alexandra S Potter
Journal:  Pharmacol Biochem Behav       Date:  2012-11-15       Impact factor: 3.533

10.  The generality of nicotine as a reinforcer enhancer in rats: effects on responding maintained by primary and conditioned reinforcers and resistance to extinction.

Authors:  Bethany R Raiff; Jesse Dallery
Journal:  Psychopharmacology (Berl)       Date:  2008-08-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.